Resmed (RMD) Stock Statistics & Valuation Metrics

Resmed has a market cap or net worth of $40.56B. The enterprise value is $37.56B.

Resmed has 146,414,840 shares outstanding. The number of shares has decreased by -2.65% in one year.

Resmed’s return on equity (ROE) is 0.23 and return on invested capital (ROIC) is 19.58%.

The current PE Ratio of Resmed is 29.1. Resmed’s PEG ratio is ―.

In the last 12 months, Resmed had revenue of 5.15B and earned 1.40B in profits. Earnings per share was 9.55.

In the last 12 months, operating cash flow was 1.75B and capital expenditures -92.86M, giving a free cash flow of 1.66B billion.

Resmed pays an annual dividend of $0.6, resulting in a dividend yield of 0.79%

Resmed upcoming earnings date is Oct 23, 2025, After Close (Confirmed).

Resmed as a current ratio of 3.34, with Debt / Equity ratio of 14.78%

In the past 12 months, Resmed has paid 276.84M in taxes.

Resmed EV to EBITDA ratio is 19.61, with an EV/FCF ratio of 22.58.

Resmed has $1.21B in cash and marketable securities with $882.32M in debt, giving a net cash position of -$327.13M billion.

Gross margin is 59.36%, with operating margin of 32.79%, and net profit margin of 27.22%.

The average price target for Resmed is $299.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy